Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,391,299 papers from all fields of science
Search
Sign In
Create Free Account
CAP18 lipopolysaccharide-binding protein
Known as:
FA-LL-37
, cathelicidin LL-37
, LL-37 peptide
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Antimicrobial Cationic Peptides
cathelicidin
Narrower (3)
Bac4 protein, Bos taurus
Cathelicidin LL-37, human
eCATH-1 protein, Equus caballus
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
M. Murakami
,
T. Kaneko
,
+7 authors
K. Sayama
PLoS ONE
2014
Corpus ID: 6712095
“Pustulosis palmaris et plantaris”, or palmoplantar pustulosis (PPP), is a chronic pustular dermatitis characterized by…
Expand
Highly Cited
2011
Highly Cited
2011
Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy
P. Sarker
,
Sultan Ahmed
,
+7 authors
R. Raqib
PLoS ONE
2011
Corpus ID: 12000921
Background Cathelicidins and defensins are endogenous antimicrobial peptides (AMPs) that are downregulated in the mucosal…
Expand
2009
2009
NF κB Activation in Embryonic Endothelial Progenitor Cells Enhances Neovascularization via PSGL‐1 Mediated Recruitment: Novel Role for LL37
A. Pfosser
,
Chiraz El-Aouni
,
+12 authors
C. Kupatt
Stem Cells
2009
Corpus ID: 28921951
Embryonal endothelial progenitor cells (eEPCs) are capable of inducing therapeutic angiogenesis in a chronic hind limb model…
Expand
Highly Cited
2006
Highly Cited
2006
Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study
Cristina D. Ciornei
,
H. Tapper
,
A. Bjartell
,
N. Sternby
,
M. Bodelsson
BMC Cardiovascular Disorders
2006
Corpus ID: 262336609
BackgroundDeath of smooth muscle cells in the atherosclerotic plaques makes the plaques more prone to rupture, which can initiate…
Expand
Highly Cited
2003
Highly Cited
2003
Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, (cid:2) -Defensins and CAP18, Expressed by Human Keratinocytes
K. Midorikawa
,
K. Ouhara
,
+9 authors
M. Sugai
2003
Corpus ID: 17465087
The antimicrobial peptides human (cid:1) -defensin-1 (hBD1), hBD2, hBD3, and CAP18 expressed by keratinocytes have been…
Expand
Highly Cited
2003
Highly Cited
2003
Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin
Ole E. Sørensen
,
L. Gram
,
+7 authors
N. Borregaard
Journal of Biological Chemistry
2003
Corpus ID: 26153602
The human cathelicidin, hCAP-18, is expressed both in neutrophils and in epithelial cells. hCAP-18 is processed to the…
Expand
Highly Cited
1997
Highly Cited
1997
An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma.
O. Sørensen
,
J. Cowland
,
J. Askaa
,
N. Borregaard
JIM - Journal of Immunological Methods
1997
Corpus ID: 24166389
Highly Cited
1995
Highly Cited
1995
Anti-microbial activity of human CAP18 peptides.
J. Larrick
,
M. Hirata
,
J. Zhong
,
S. C. Wright
Immunotechnology
1995
Corpus ID: 22868947
Highly Cited
1994
Highly Cited
1994
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity
M. Hirata
,
Yuko Shimomura
,
+6 authors
James W. Larrick
Infection and Immunity
1994
Corpus ID: 23035918
Cationic antibacterial proteins (CAP) were purified from rabbit granulocytes, and the effects of CAP on lipopolysaccharide (LPS…
Expand
Highly Cited
1991
Highly Cited
1991
Complementary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein.
J. Larrick
,
J. G. Morgan
,
I. Palings
,
M. Hirata
,
Michael H. Yen
Biochemical and Biophysical Research…
1991
Corpus ID: 24596350
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required